Author(s):
N. Koteshwara Rao, N. Priya Darshini, N. Usha Rani
Email(s):
priyadarshini.namburi7@gmail.com
DOI:
10.52711/2454-2652.2025.00009 
Address:
N. Koteshwara Rao1, N. Priya Darshini2, N. Usha Rani3
1M.Sc Nursing II Year Student, NRI College of Nursing, Guntur AP.
2Associate Professor in Medical Surgical Nursing, NRI College of Nursing, Guntur AP.
3Associate Professor Cum HOD in Medical Surgical Nursing, NRI College of Nursing, Guntur AP.
*Corresponding Author
Published In:
Volume - 13,
Issue - 1,
Year - 2025
ABSTRACT:
The Aim of the Study is to assess the Effectiveness of Topical Application of Honey in the Management of Chemo Radiation Therapy Induced Oral Mucositis among Cancer Survivors. Materials and methods: True Experimental pre-test post-test with control group research design is used to achieve the objective of the study; Systematic Random Sampling technique is used to select the sample. A sample of 60 Cancer survivors with chemo-radiation induced oral mucositis. Experimental group (N=30), Control group (N=30) is selected as sample and Data were collected by using structured knowledge questionnaire using Socio Demographic data, Clinical Data and WHO oral toxicity scale. The collected data were analyzed by using Frequency and percentage distribution, inferential statistics and Chi-square test Results: The findings of the study revealed that majority of the cancer survivors were in the age group of 41-50 years i.e., 33.3% in the experimental group and % in the control group. Similarly, males constitute most in the both groups i.e., 53.3% in the experimental group and 70% in the control group. All the participants completed more than 6 radiation cycles in both groups were i.e., 100% in the experimental group and 100% in the control group. Most of them had 25-50 Millimeters mean and radiation area i.e., 93.3% in the experimental group and 53.3% in the control group. Majority of them were undergone more than 6 weeks cycles of chemotherapy i.e., 93.7% in the experimental group and 83.3% in the control group. Around 40% of them were smokers in i.e., the experimental group and 63.3% in the control group. Majority of them were diagnosed with non- hematological carcinoma. I.e., 93.7% in the experimental group and 70% in the control group. Both groups were similar in their baseline characteristics (p>0.05). during pre-test around 6.6% of the cancer survivors in the experimental group had Grade 1 Oral Mucositis and 20.6% in control group had Grade 1 Oral Mucosities, about 23.3% of them had Grade II Oral Mucositis in experimental group and 46.7% in control group, around 43.3% in the experimental group and 26.7% in the control group had Grade III Oral Mucositis, 6% of cancer survivors in the experimental group and 6.7% in the control group had Grade IV Oral Mucositis. To test the homogeneity of the outcome measure (Oral Mucosities Grades) at baseline, Chi-square test was computed and it was found that, both the groups were similar at their baseline measure (p>0.05). The comparison of level of oral mucositis between the experimental and the control groups during pretest, posttest I, II, III and IV. The results revealed that, During Pre-test and post-test I, around 6.6% of the 58 cancer survivors in the experimental group had Grade 1 Oral Mucositis and 20.6% in control group had Grade 1 Oral Micro sites, about 23.3% of them had Grade II Oral Mucositis in experimental group and 46.7% in control group, around 43.3% in the experimental group and 26.7% in the control group had Grade III Oral Mucositis, and 6% of cancer survivors in the experimental group and 6.7% in the control group had Grade IV Oral Mucositis. The chi-square results revealed that there is no significant difference in both the groups regarding level oral mucositis (Grades) during pre-test and posttest I at p>0.05. During post-test II, none of them in the experimental group had Grade 1 Oral Mucositis and only 6.7% in the control group had Grade 1 Oral Micro sites, about 20.0% of them had Grade II Oral Mucositis in the experimental group and 33.7% in control group, around 56.7% in the experimental group and 40.0% in the control group had Grade III Oral Mucositis and 23.3% of cancer survivors in the experimental group and 20.0% in the control group had Grade IV Oral Mucositis. The chi-square results revealed that there is a significant difference in both the groups regarding level oral mucositis (Grades) during posttest II at p Conclusion: The main conclusion of the present study is oral honey application was effective in reducing oral mucositis among patients with cancer which is denoted by significant level of oral mucositis. After the intervention there had been a significant reduction in level of oral mucositis. The selected subjects became familiar and found themselves comfortable and also expressed satisfaction.
Cite this article:
N. Koteshwara Rao, N. Priya Darshini, N. Usha Rani. Effectiveness of Topical Application of Honey in the Management of Chemo Radiation Therapy Induced Oral Mucositis among Cancer Survivors in a selected Oncology Hospital at Chinakakani, Guntur (DT) AP. International Journal of Advances in Nursing Management. 2025;13(1):41-5. doi: 10.52711/2454-2652.2025.00009
Cite(Electronic):
N. Koteshwara Rao, N. Priya Darshini, N. Usha Rani. Effectiveness of Topical Application of Honey in the Management of Chemo Radiation Therapy Induced Oral Mucositis among Cancer Survivors in a selected Oncology Hospital at Chinakakani, Guntur (DT) AP. International Journal of Advances in Nursing Management. 2025;13(1):41-5. doi: 10.52711/2454-2652.2025.00009 Available on: https://ijanm.com/AbstractView.aspx?PID=2025-13-1-9
REFERENCES:
1. Abuharfeil, N., Oran, L., Shehada, M. The effects of bee honey on the proliferative activity of human B and T lymphocytes and activity of phagocytes. Food and Agricultural Immunology 2008: 169- 177.
2. Feeley. The Changing Face of Cancer. Asian Hospital and Health Care Management. 2008; 15: 27-29.
3. Cancer statistics. (2009). WHO? Retrieved from http// www.asian htm.com on 15th June 2010
4. Scully, C., Epstein, J.B. Oral health care for the cancer patient. Oral Oncology European Journal on Cancer. 1996; 281-292.
5. Hanyu, N. Utilization of complementary and alternative medicine by United States Adults: Interview Survey. Medical Care. 2002; 40(4): 253-358.
6. Feeley. The Changing Face of Cancer. Asian Hospital and Health Care Management. 2008; 15: 27-29.
7. Cancer Statistics. (2009). WHO? Retrieved from http// www.asian htm.com on 15th June 2010.
8. Liza, G., Ovington, L.G. Honey: Ancient cure or modern alternative? Wound Care Newsletter. 1999: 1-3.
9. Scully, C., Epstein, J.B. Oral health care for the cancer patient. Oral Oncology European Journal on Cancer. 1996; 281-292.
10. Molan, P C. The antibacterial activity of honey. Bee World. 1992; 5- 28.
11. Waili, N.S., Boni, N. S. Natural honey lowers plasma prostaglandin concentrations in normal individuals. Journal of Medicinal Food. 2003; 129-133.